Related Experiment Video
Updated: Aug 15, 2026
Rapid Homogeneous Detection of Biological Assays Using Magnetic Modulation Biosensing System
Published on: June 13, 2010
Vancomycin-conjugated polydopamine-coated magnetic nanoparticles for molecular diagnostics of Gram-positive bacteria
Abdurhaman Teyib Abafogi1, Tepeng Wu2, Daekyu Lee1
1School of Mechanical Engineering, Sungkyunkwan University (SKKU), Seobu-ro 2066, Jangan-gu, Suwon, 16419, Korea.
Background:
Sepsis is caused mainly by infection in the blood with a broad range of bacterial species. It can be diagnosed by molecular diagnostics once compounds in the blood that interfere with molecular diagnostics are removed. However, this removal relies on ultracentrifugation. Immunomagnetic separation (IMS), which typically uses antibody-conjugated silica-coated magnetic nanoparticles (Ab-SiO2-MNPs), has been widely applied to isolate specific pathogens in various types of samples, such as food and environmental samples. However, its direct use in blood samples containing bacteria is limited due to the aggregation of SiO2-MNPs in the blood and inability to isolate multiple species of bacteria causing sepsis.
Results:
In this study, we report the synthesis of vancomycin-conjugated polydopamine-coated (van-PDA-MNPs) enabling preconcentration of multiple bacterial species from blood without aggregation. The presence of PDA and van on MNPs was verified using transmission electron microscopy, X-ray photoelectron spectroscopy, and energy disruptive spectroscopy. Unlike van-SiO2-MNPs, van-PDA-MNPs did not aggregate in the blood. Van-PDA-MNPs were able to preconcentrate several species of Gram-positive bacteria in the blood, lowering the limit of detection (LOD) to 10 colony forming units/mL by polymerase chain reaction (PCR) and quantitative PCR (qPCR). This is 10 times more sensitive than the LOD obtained by PCR and qPCR using van-SiO2-MNPs.
Conclusion:
These results suggest that PDA-MNPs can avoid aggregation in blood and be conjugated with receptors, thereby improving the sensitivity of molecular diagnostics of bacteria in blood samples.
Insights
New vancomycin-conjugated polydopamine-coated magnetic nanoparticles (van-PDA-MNPs) effectively capture multiple sepsis-causing bacteria from blood without aggregation. This enhances molecular diagnostic sensitivity, improving sepsis detection limits.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Molecular Diagnostics
Background:
- Sepsis diagnosis is hindered by interfering blood compounds, requiring ultracentrifugation for removal.
- Current immunomagnetic separation (IMS) using silica-coated magnetic nanoparticles (SiO2-MNPs) faces aggregation and multi-species isolation challenges in blood.
Purpose of the Study:
- To develop novel magnetic nanoparticles (MNPs) for efficient and non-aggregating capture of diverse sepsis-causing bacteria from blood.
- To enhance the sensitivity of molecular diagnostic methods for bacterial detection in blood samples.
Main Methods:
- Synthesis of vancomycin-conjugated polydopamine-coated magnetic nanoparticles (van-PDA-MNPs).
- Characterization of van-PDA-MNPs using transmission electron microscopy, X-ray photoelectron spectroscopy, and energy disruptive spectroscopy.
- Evaluation of van-PDA-MNPs' performance in preconcentrating bacteria from blood and subsequent molecular detection via PCR and qPCR.
Main Results:
- Van-PDA-MNPs were successfully synthesized and characterized, confirming the presence of polydopamine (PDA) and vancomycin.
- Unlike vancomycin-conjugated silica-coated magnetic nanoparticles (van-SiO2-MNPs), van-PDA-MNPs exhibited no aggregation in blood samples.
- Van-PDA-MNPs effectively preconcentrated multiple Gram-positive bacterial species, achieving a 10 colony forming units/mL limit of detection (LOD) via PCR and qPCR, a tenfold improvement over van-SiO2-MNPs.
Conclusions:
- Polydopamine-coated magnetic nanoparticles (PDA-MNPs) effectively prevent aggregation in blood.
- PDA-MNPs can be functionalized with specific receptors for targeted analyte capture.
- This approach significantly enhances the sensitivity of molecular diagnostics for bacterial detection in blood, offering a promising tool for sepsis diagnosis.
